Drugs / house dust mites allergen extract
house dust mites allergen extract
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01919554 | Jul → Sep 2013 | allergic rhinitis | Stallergenes Greer | Completed | No outcome recorded |
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT01527188 | Dec 2010 → Mar 2012 | allergic rhinitis | Stallergenes Greer | Completed | Met primary |
| Comparator or background therapy2 trials | ||||||
| Phase 2/3 | NCT00674700 Comparator | Oct 2007 → Feb 2009 | allergic rhinitis | Stallergenes Greer | Completed | No outcome recorded |
| Phase 4 | NCT01052610 Comparator | Jun 2010 → Sep 2013 | allergic rhinitis, asthma | Medical University of Lodz | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | house dust mites allergen extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01527188 ↗ |
| Modality | Other / unclassified | “house dust mites allergen extract tablet” NCT01527188 ↗ |
| Route | Other | “One sublingual tablet daily during 6 months” NCT01527188 ↗ |